IndiaInfoline » Markets » LALPATHLAB

Dr Lal Pathlabs Ltd - Share Price

LALPATHLAB

Open

1,532.00

Prev. Close

1,535.95

Turnover (lac.)

2,568

Day's High

1,565.00

Day's Low

1,506.20

52 Week's High

1,698.50

52 Week's Low

890.95

Book Value

131

Face Value

10

Mkt Cap (Cr.)

12,903

P/E

56.65

EPS

27.25

Divi. Yield

0.39

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Apollo Hospitals Enterprise Ltd1,390.4558.1019,373.1690.600.432,463.58266.78
Dr Lal Pathlabs Ltd1,548.2556.6512,866.2879.500.39351.20124.96
Fortis Healthcare Ltd135.0014.5010,191.94-13.270.00181.40116.85
Aster DM Healthcare Ltd149.15149.447,474.84-4.340.00200.6058.79
Metropolis Healthcare Ltd1,292.4055.596,502.4031.681.02172.2892.41

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Dr. Lal PathLabs has built a national, hub and ... More

Registered Office

E-2 Block Sector 18,Rohini,New Delhi, New Delhi,110085

Tell. : +91-011-3024 4149
Website : http://www.lalpathlabs.com
Email : cs@lalpathlabs.com

Registrar Office

Noble Heights 1st Fl, LSC Janakpuri, New Delhi - 110058 INDIA

Tell. : +91-11-41410592/93/94
Website : www.linkintime.co.in
Email : delhi@linkintime.co.in

Latest Release by dr-lal-pathlabs-ltd

View

- <

Reco. Price

Nov 09,2019 12:43 PM

Target Price

Target Returns:

0.00%

Result Express

Dr. Lal PathLabs Ltd's Q3FY19 consolidated net profit rises 28.06% yoy to Rs46.10cr : Beats Estimates

Dec 12, 2019 12:58 AM

The company’s consolidated revenue stood at Rs292.50cr, up 11.34% yoy but down 7.87% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    08 Nov 2019

    Effective. Date

    20 Nov 2019

    Divi. Type

    Interim

    Divi.(%)

    60

    Divi. Amt.

    6

    Dr. Lal PathLabs Ltd has informed BSE that the Board of Directors of the Company at its meeting held... More

  • Purpose

    Board Meeting

    Exp. Date

    08 Nov 2019

    Annc. Date

    18 Oct 2019

    Interim Dividend & Quarterly ResultsDear Sir/Madam,Please take note that the Board of Directors in t... More